Valuation: TAUNS Laboratories,Inc.

Market Cap 5.57TCr 35Cr 31Cr 29Cr 27Cr 50Cr 3.4TCr 50Cr 352.61Cr 136.18Cr 1.73TCr 132.95Cr 130.07Cr P/E 2026 *
10.5x
P/E 2027 * 15.5x
Enterprise Value 6.37TCr 40Cr 36Cr 34Cr 31Cr 57Cr 3.89TCr 58Cr 403.19Cr 155.71Cr 1.98TCr 152.01Cr 148.72Cr EV / Sales 2026
-
EV / Sales 2027 * 3.35x
Free-Float
31.29%
Yield 2026 *
6.76%
Yield 2027 * 5.36%
1 day-0.96%
1 week-1.90%
Current month+2.17%
1 month+2.17%
3 months+10.23%
6 months+0.39%
Current year+1.57%
1 week 513
Extreme 513
534
1 month 500
Extreme 500
534
Current year 463
Extreme 463
568
1 year 463
Extreme 463
577
3 years 401
Extreme 401
733
5 years 401
Extreme 401
733
10 years 401
Extreme 401
733
Manager TitleAgeSince
Chief Executive Officer 51 01/05/2014
Comptroller/Controller/Auditor - -
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 51 01/05/2014
Director/Board Member 53 01/04/2016
Director/Board Member 43 01/09/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-1.90%-8.33% - 35Cr
+0.05%+1.99%+195.40%+489.92% 2.38TCr
+3.26%+11.88%+655.12%+114.55% 1.15TCr
+2.57%+10.24%-29.47%-9.98% 1.07TCr
-0.72%+3.59%+8.77% - 897.24Cr
0.00%-0.54%+97.08%+43.45% 651.03Cr
+3.94%+1.14%-27.39%-21.90% 580.58Cr
+0.61%+1.67%+6.93%-6.20% 446.2Cr
-4.05%-7.21%+53.55%+58.57% 369.82Cr
+1.43%+4.95%-13.29%-25.37% 290.48Cr
Average +0.61%+2.75%+93.84%+80.38% 787.01Cr
Weighted average by Cap. +0.94%+4.12%+160.47%+189.46%

Financials

2026 2027 *
Net sales 1.48TCr 9.37Cr 8.25Cr 7.8Cr 7.07Cr 13Cr 899.89Cr 13Cr 93Cr 36Cr 459.19Cr 35Cr 34Cr 1.93TCr 12Cr 11Cr 10Cr 9.23Cr 17Cr 1.17TCr 17Cr 121.79Cr 47Cr 599.1Cr 46Cr 45Cr
Net income 520.13Cr 3.3Cr 2.91Cr 2.75Cr 2.49Cr 4.68Cr 317.2Cr 4.71Cr 33Cr 13Cr 161.86Cr 12Cr 12Cr 359.27Cr 2.28Cr 2.01Cr 1.9Cr 1.72Cr 3.23Cr 219.1Cr 3.25Cr 23Cr 8.78Cr 111.8Cr 8.57Cr 8.38Cr
Net Debt 799.4Cr 5.08Cr 4.47Cr 4.22Cr 3.83Cr 7.19Cr 487.51Cr 7.24Cr 51Cr 20Cr 248.77Cr 19Cr 19Cr 875.45Cr 5.56Cr 4.89Cr 4.63Cr 4.2Cr 7.88Cr 533.89Cr 7.93Cr 55Cr 21Cr 272.43Cr 21Cr 20Cr
Logo TAUNS Laboratories,Inc.
Tauns Laboratories Inc is a Japan-based company engaged in the business of developing, manufacturing and marketing in vitro diagnostic products and research reagents. The Company operates its business in the in vitro diagnostic products business segment. The Company’s main product is antigen test kit that uses immunochromatography to enable rapid diagnosis at the patient's side without the need for special equipment. The products include ImunoAce Flu, ImunoAce SARSCoV-2 II, ImunoAce SARSCoV-2 Saliva, ImunoAce SARSCoV-2/Flu, ImunoAce Adeno, ImunoAce Strep A Neo, ImunoAce hMPV, ImunoAce Mycopiasma, ImunoAce RSV Neo and ImunoAce Noro.
Employees
218
Date Price Change Volume
29/26/29 JP¥517.00 -0.96% 1,54,500
28/26/28 JP¥522.00 -1.14% 1,41,800
25/26/25 JP¥528.00 +0.19% 2,26,900
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
522.00JPY
Average target price
430.00JPY
Spread / Average Target
-17.62%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 197A Stock